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Recently found bat-derived inﬂuenza viruses (BatIVs) have hemagglutinin (HA) and neuraminidase (NA)
gene segments distinct from those of previously known inﬂuenza A viruses. However, pathogenicities of
these BatIVs remain unknown since infectious virus strains have not been isolated yet. To gain insight
into the biological properties of BatIVs, we generated vesicular stomatitis viruses (VSVs) pseudotyped
with the BatIV HA and NA. We found that VSVs pseudotyped with BatIV HAs and NAs efﬁciently infected
particular bat cell lines but not those derived from primates, and that proteolytic cleavage with a trypsin-
like protease was necessary for HA-mediated virus entry. Treatment of the susceptible bat cells with
some enzymes and inhibitors revealed that BatIV HAs might recognize some cellular glycoproteins as
receptors rather than the sialic acids used for the other known inﬂuenza viruses. These data provide
fundamental information on the mechanisms underlying the cellular entry and host restriction of BatIVs.
& 2015 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza A viruses (IAVs), which belong to the family Ortho-
myxoviridae, have 8 segmented negative sense RNA genomes. IAV is
one of the most important zoonotic pathogens, with high morbidity
in humans, pigs, horses, and poultry. IAVs have two envelope gly-
coproteins, hemagglutinin (HA) and neuraminidase (NA), and are
divided into subtypes based on antigenicity. IAVs of H1–16 HA and
N1–9 NA subtypes have been isolated from water birds such as
migratory ducks, the natural reservoir of IAVs (Fouchier et al., 2005;
Kida and Yanagawa, 1979; Webster et al., 1992).
HAs are expressed as trimers on the virion surface (Wilson et
al., 1981). HA is initially synthesized as an inactive precursor HA0
and subsequently cleaved into HA1 and HA2 subunits by trypsin-
like proteases of host cells (Sakai et al., 2014). The proteolytic
cleavage of the HA molecule is essential for IAVs to acquire
infectivity (Lazarowitz et al., 1973; Wiley and Skehel, 1987). HA1 is
responsible for virus binding to sialic acid receptors on the cell
surface, and HA2 mediates membrane fusion under acidic condi-
tions in endosomes, thereby delivering the viral genomic RNA into
the cytoplasm of target cells (Matlin et al., 1981; Rust et al., 2004).Zoonosis Control, Hokkaido
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ada).NAs, expressed on the virion surface as tetramers, have sialidase
activity that enables mature virus particles to be released from
infected cells after budding (Colman, 1994; Webster et al., 1992).
Recently, IAV-like RNA genomes were detected in succession
from 2 frugivorous bat species, little yellow-shouldered bats (Stur-
nira lilium) and ﬂat-faced fruit bats (Artibeus planirostris) in Guate-
mala and Peru, respectively. The nucleotide sequences of the HA
and NA of these bat-derived inﬂuenza viruses (BatIVs) were diver-
gent from all previously known IAVs and new subtypes, H17N10
and H18N11, have been proposed (Tong et al., 2012, 2013). However,
infectious viruses have not been isolated yet. Previous studies by
others tried to rescue BatIVs using a reverse genetics approach, but
failed to generate infectious BatIVs (Juozapaitis et al., 2014; Zhou
et al., 2014). Thus, the information on the biological properties of
BatIVs is mostly speculative and the possible functions of BatIV HAs
and NAs are only hypothetical, based on structural analyses (Li
et al., 2012; Tong et al., 2013; Zhu et al., 2012, 2013).
In this study, we utilized a vesicular stomatitis virus (VSV)
pseudotype system, enabling us to directly analyze the biological
functions of the BatIV glycoproteins, which presumably play
important roles in the replication cycle and pathogenicity. We
found some bat cell lines susceptible to VSVs pseudotyped with
BatIV HAs and NAs. Our data suggest that BatIVs do not use sialic
acids as a viral receptor and may have a limited host range, at least
considering receptor engagement.
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Generation of VSVs pseudotyped with BatIV HAs and/or NAs
To investigate cellular entry mediated by BatIV glycoproteins,
VSVs pseudotyped with BatIV HAs and/or NAs (VSVΔG*-H17N10,
-H18N11, -H17, -H18, -N10, and -N11) were generated as described
in Materials and Methods. We ﬁrst observed the virions of these
pseudotyped VSVs using transmission electron microscopy (Fig. 1).
We found that the virions of all of these pseudotyped VSVs
showed characteristic morphology (i.e. a bullet-like shape) similar
to parental VSVΔG*-G. It was noted that VSVs pseudotyped with
BatIV HA and NA (Fig. 1A and B), HA alone (Fig. 1D and E), and NA
alone (Fig. 1G and H) all had numerous spikes on their surfaces, as
was the case with VSVs pseudotyped with IAV HA (H3) and NA
(N2) (Fig. 1C), H3 HA alone (Fig. 1F), and N2 NA alone (Fig. 1I).
Immune electron microscopy with anti-H17 HA and anti-N10 NA
antibodies revealed that both BatIV HA and NA were efﬁciently
incorporated into VSV particles (Fig. 1K and L). No difference was
found in the overall morphology among these VSV virions. TheseFig. 1. Transmission electron microscopy of pseudotyped VSVs. VSVΔG*-H17N10 (A), -H
VSVΔG*-G (J) were ﬁxed and stained as described in Materials and Methods. For imm
antibody (K) and anti-N10 NA mouse serum (L) were used. Scale bars represent 100 nmdata indicated that BatIV HAs and NAs were efﬁciently incorpo-
rated into the VSV particles.
Cell lines susceptible to VSVs pseudotyped with BatIV glycoproteins
Since previous studies have suggested that cell lines commonly
used for IAV propagation are nonpermissive for BatIVs, we
screened various cell lines, including bat-derived cells, for
susceptibility to pseudotyped VSVs (Table 1) (Fig. 2). VSVs pseu-
dotyped with HAs and NAs of BatIVs and well-characterized IAV
strains, A/WSN/1933 (H1N1) (WSN) and A/Aichi/2/1968 (H3N2)
(Aichi), were generated and treated with trypsin before use, since
BatIV HAs, like WSN and Aichi HAs, have a cleavage site potentially
recognized by trypsin-like proteases (Tong et al., 2012, 2013). We
found that VSVΔG*-WSN, -Aichi, and -VSV G infected all cell lines
tested (Fig. 2A, B, and E). On the other hand, VSVΔG*-H17N10 and
-H18N11 infected bat cell lines YubFKT1, IndFSPT1, and SuBK12-08,
but not the other cell lines tested, except MDCK cells, which were
much less susceptible than these bat cells. Since IndFSPT1 cells
showed the highest susceptibility to VSVΔG*-H17N10 and18N11 (B), -H3N2 (C) -H17 (D), -H18 (E), -H3 (F), -N10 (G), -N11 (H), -N2 (I) and
une transmission electron microscopy of VSVΔG*-H17N10, anti-HA2 monoclonal
. Arrowheads indicate gold particles.
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Fig. 2. Infectivities of pseudotyped VSVs in several cell lines. VSVΔG*-WSN, -Aichi, -H
Infectious units (IUs) of each virus in different cell lines were determined by counting th
averages and standard deviations are shown. Infectivities of VSVΔG*-H17N10 and -H18
(student's t-test) were found between MDCK and any of the bat cell lines (Po0.01).
Table 1
Origins of cell lines used in this study.
Cell line Species Zoological name Organ
Vero E6 African green monkey Chlorocebus sp. Kidney
HEK293 Human Homo sapiens Kidney
MDCK Dog Canis lupus familiaris Kidney
SK-L Pig Sus scrofa domesticus Kidney
QT6 Japanese quail Coturnix japonica Muscle
BKT1 Greater horseshoe bata Rhinolophus ferrumequinum Kidney
FBKT1 Yaeyama ﬂying foxa Pteropus dasymallus
yayeyamae
Kidney
YubFKT1 Eastern bent-winged bata Miniopterus fuliginosus Kidney
IndFSPT1 Indian ﬂying foxa Pteropus giganteus Spleen
DemKT1 Leschenault's rousettea Rousettus leschenaultii Kidney
ZFBK11-97 Gambian epauletted fruit
bata
Epomophorus gambianus Kidney
SuBK12-08 Schreiber's bata Miniopterus schreibersii Kidney
ZFBS13-75A Straw-colored fruit batb Eidolon helvum Spleen
a Previously described (Maruyama et al., 2014).
b Determined by habitat and morphology.
J. Maruyama et al. / Virology 488 (2016) 43–50 45-H18N11 (Fig. 2C and D), this cell line was used for the following
experiments.
Trypsin requirement for the HA function and the dispensability of NA
in virus entry
IAV HAs are known to be cleaved into HA1 and HA2 subunits by
trypsin-like proteases to acquire the ability to mediate membrane
fusion (Klenk and Rott, 1988). Western blotting revealed that both
H17 and H18 HAs were cleaved into HA1 and HA2 by trypsin
treatment (Fig. 3A). Thus, we investigated the requirement of HA
cleavage for infectivity of pseudotyped VSVs. As expected, VSVs
pseudotyped with BatIV glycoproteins did not infect IndFSPT1 cells
without trypsin treatment, in a manner consistent with other IAVs
(data not shown), whereas trypsin-treated viruses efﬁciently
infected this cell line (Fig. 2). These data indicated that the HA
cleavage was a prerequisite for BatIV infectivity. Next, to clarify
whether BatIV HAs was responsible for virus entry, VSVΔG*-
H17N10, -H18N11,-H17, -H18, -N10, and -N11 were inoculated to1
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17N10, -H18N11, and VSVΔG*-G were inoculated into several cell lines (Table 1).
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Fig. 3. Infectivities of pseudotyped VSVs with BatIV HAs and/or NAs in IndFSPT1 cells. (A) VSVΔG*-Aichi, -H17N10, and -H18N11 were treated with or without trypsin (ﬁnal
concentration 0.0005%) for 30 min at 37 °C and then mixed with SDS-PAGE sample buffer with 5% 2-mercaptoethanol. After SDS-PAGE, separated proteins were detected by
western blotting with anti-H3 chicken antiserum and anti-HA2 monoclonal antibody 3N12-6-4. (B) VSVs pseudotyped with HAs and/or NAs of WSN and Aichi and VSVΔG*-
H17N10, -H17, -N10, -H18N11, -H18, and -N11 were inoculated to IndFSPT1 cells. Infectious units (IUs) were determined by counting the number of GFP-expressing cells. Each
experiment was performed three times, and averages and standard deviations are shown. Infectivities of VSV pseudotyped with NAs alone were under the limit of detection
(†). Statistical signiﬁcance was calculated using student's t-test (*Po0.01).
J. Maruyama et al. / Virology 488 (2016) 43–5046IndFSPT1 cells and their infectivities were compared (Fig. 3B). We
found that VSVΔG*-H17 and -H18 infected IndFSPT1 cells as efﬁ-
ciently as VSVΔG*-H17N10 and -H18N11, whereas the infectivity
of VSV pseudotyped with WSN or Aichi HA alone was much lower
than that of VSVs pseudotyped with both HA and NA of the
respective viruses. VSVΔG*-N10 and -N11 showed no infectivity,
similarly to VSVs pseudotyped with NAs of WSN and Aichi. These
results suggest that BatIV HA is the only glycoprotein mediating
both virus attachment and membrane fusion and that BatIV NA is
dispensable during the entry into cells.
Effects of chemical and enzymatic treatments of cells on susceptibility
to VSVs pseudotyped with BatIVs
It is generally known that IAV HAs mediate membrane fusion in
a low pH-dependent manner (Kida et al., 1983; Rust et al., 2004).
To investigate the requirement of endosomal acidiﬁcation for BatIV
HA-mediated membrane fusion, IndFSPT1 cells were treated with
ammonium chloride, which is known to neutralize the pH of acidic
intracellular compartments, and then infected with VSVΔG*-WSN,
-Aichi, -H17N10, -H18N11, and VSVΔG*-G. Treatment of the cells
with ammonium chloride markedly reduced the infectivity of
VSVΔG*-H17N10 and -H18N11, as was the case with VSVΔG*-G,
-WSN, and -Aichi, in a dose-dependent manner, suggesting that
BatIV HAs require a low pH for membrane fusion, consistent with
the other IAV HAs (Fig. 4A). To obtain information on the biological
characteristics of cellular receptors for BatIVs, IndFSPT1 cells were
pretreated with tunicamycin, pronase, or neuraminidase (i.e., an
N-linked glycosylation inhibitor, mixture of proteases, and siali-
dase, respectively), and then infected with pseudotyped VSVs
(Fig. 4B–D). Tunicamycin treatment markedly reduced the infec-
tivities of VSVΔG*-G, -H17N10, and -H18N11, but less signiﬁcantly
those of VSVΔG*-WSN and -Aichi (Fig. 4B). Preincubation of cells
with pronase reduced the infectivities of the pseudotyped VSVs,
except for VSVΔG*-WSN (Fig. 4C). Neuraminidase treatment
reduced VSVΔG*-WSN and -Aichi infectivities, but interestingly
did not affect the infectivities of VSVΔG*-H17N10 and -H18N11
(Fig. 4D). We conﬁrmed that no remarkable cytotoxicity was
observed during these treatments (Fig. 4E). These results suggest
that BatIV HAs do not recognize sialic acids which are critical
components of the IAV receptor and some other molecules such as
glycoproteins may serve as BatIV receptors.Discussion
In recent years, particular attention has been paid to bat-
derived viruses since some species of bats have been reported to
be reservoirs of several viral zoonotic pathogens (e.g., lyssavirus,
henipavirus, SARS coronavirus, and Marburgvirus) (Calisher et al.,
2006; Smith and Wang, 2013; Wang et al., 2011, 2007). Although
the zoonotic potential of BatIVs has not been fully evaluated yet,
recent studies generated reassortant viruses that had HA and NA
gene segments of well-characterized IAVs (i.e., H1, H3, and H7 HAs
and N1, N2, and N7 NAs) and the other gene segments derived
from BatIVs, and demonstrated that the reassortant viruses repli-
cated in cultured cells and caused severe disease in mice (Juoza-
paitis et al., 2014; Zhou et al., 2014). However, characterization of
BatIV HAs and NAs remains an open research problem, since
reassortant viruses carrying the BatIV HA and NA gene segments
have not been rescued due to the lack of information on cells
susceptible to this novel virus. In this study, we ﬁrst determined
the potentially permissive bat cell lines using VSVs pseudotyped
with BatIV HAs and NAs.
We demonstrated that VSVΔG*-H17N10 and -H18N11 efﬁ-
ciently infected the bat-derived cell lines IndFSPT1, YubFKT1, and
SuBK12-08. While IndFSPT1 was derived from Pteropus giganteus
(family Pterodidae), YubFKT1 and SuBK12-08 were prepared from
bats belonging to the same species (Miniopterus sp., family Mini-
opteridae). Based on a phylogenetic study of bats (Agnarsson et al.,
2011), Miniopteridae belongs to the same cluster as Phyllostomidae,
from which H17N10 and H18N11 BatIVs were detected, little
yellow-shouldered bats (S. lilium) and ﬂat-faced fruit bats (A. pla-
nirostris), respectively (Tong et al., 2012, 2013). Thus, BatIV HAs
appear to recognize cell surface molecules shared among the bats
at least in Miniopteridae and Phyllostomidae families. IndFSPT1
should also have such molecules since it showed the highest
susceptibility to BatIV HA-pseudotyped VSVs. It was noted that
VSVΔG*-H17N10 and -H18N11 also infected MDCK cells, although
less efﬁciently than these bat cell lines. This result might contra-
dict a previous report that H17 HA did not bind to the surface of
MDCK cells (Sun et al., 2013). However, it is conceivable that the
binding afﬁnity of BatIV HA to MDCK cell surface molecules is
quite low and thus below the level of detection in the assay used
in the previous study. In the present study, MDCK cells indeed
showed much lower susceptibility to BatIV HA-pseudotyped VSVs
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Fig. 4. Effects of chemical and enzymatic modiﬁcation on infectivities of pseudotyped VSVs. IndFSPT1 cells were treated with ammonium chloride (A), tunicamycin (B),
pronase (C), or neuraminidase (D) as described in Materials and Methods. Treated cells were then infected with VSVΔG*-WSN, -Aichi, -H17N10, -H18N11, and VSVΔG*-G
appropriately diluted to yield 200–1000 IUs. The percentages of infectivity were determined by setting the number of the untreated cells to 100%. Each experiment was
performed three times, and averages and standard deviations are shown. Cell viabilities were measured by the alamar blue assay (E). The percentages of ﬂuorescence were
determined by setting the number of the untreated cells to 100%. Each experiment was performed three times, and averages and standard deviations are shown. Statistical
signiﬁcances compared to untreated cells were calculated using student's t-test (*Po0.01).
J. Maruyama et al. / Virology 488 (2016) 43–50 47than YubFKT1, IndFSPT1, and SuBK12-08. Nonetheless, it would be
interesting to clarify whether MDCK cells express some BatIV
receptor molecules shared with the bat cell lines.
It is also noteworthy that VSVΔG*-H17N10 and -H18N11 did not
infect Vero E6, HEK293, SK-L, and QT6 cells. Previous studies show
that quails can act as an intermediate host in the interspecies
spread of avian IAVs (Makarova et al., 2003; Perez et al., 2003;
Uchida et al., 2011). Furthermore, pigs are thought to serve as
“mixing vessels” for the production of reassortant viruses between
avian and human IAVs (Chang et al., 2009; Hinshaw et al., 1981; Ito
et al., 1998; Kida et al., 1994; Scholtissek et al., 1985). Our results
suggest that BatIVs do not readily infect humans, pigs, or birds and
support that notion that these viruses have limited zoonotic
potential (Juozapaitis et al., 2014; Zhou et al., 2014).
It is known that VSV G protein and IAV HA recognize ubiquitous
cell surface molecules for virus entry. VSV G recognizes various cellsurface molecules and thus VSV exhibits remarkably robust and
pantropic infectivity (Finkelshtein et al., 2013; Johannsdottir et al.,
2009; Lichty et al., 2004; Roche et al., 2008). IAV HAs recognize sialic
acids typically occupying the terminal positions of glycoproteins or
glycolipids (Gambaryan et al., 2005; Suzuki et al., 2000). Accordingly,
VSVΔG*-G, -WSN, and -Aichi infected all cell lines used in this study,
whereas we found that VSVΔG*-H17N10 and -H18N11 infected only
particular bat cell lines and that neuraminidase treatment did not
affect the infectivities of VSVΔG*-H17N10 and -H18N11. This result
was in agreement with previous results based on the crystal structure
analysis and surface plasmon resonance of sialylated glycans with
α2,3-linkage or α2,6-linkage (Sun et al., 2013; Zhu et al., 2013). Glycan
microarray analyses also showed that H17 HA did not display obvious
avidity to any glycans (Sun et al., 2013). Interestingly, we found that
the infectivities of VSVΔG*-H17N10 and -H18N11 were markedly
reduced by the treatment of IndFSPT1 cells with tunicamycin, which
J. Maruyama et al. / Virology 488 (2016) 43–5048inhibits N-linked glycosylation, leading to unfolding or misfolding of
proteins and inhibition of glycoprotein expression. Pretreatment of the
cells with pronase also reduced the infectivities of VSVΔG*-H17N10
and -H18N11. Taken together, our data suggest that some particular
glycoprotein(s) serve as receptors for BatIVs.
Previous studies indicated that N10 NA did not have sialidase
activity (Li et al., 2012; Zhu et al., 2012). It was also shown that
most of the amino acid residues responsible for NA activity were
substituted, and proposed that N10 NA protein should be termed
an NA-like protein (Zhu et al., 2012). In this study, we found that
VSVs pseudotyped with BatIV NAs alone were not infectious,
conﬁrming that NA did not play a central role in IAV entry into
cells. However, it should be noted that the production efﬁciency of
pseudotyped VSVs bearing WSN and Aichi HAs alone was much
lower than that of VSVs pseudotyped with both HAs and NAs,
suggesting that NA activity facilitated virus release from infected
cells and/or increased the HA function (Su et al., 2009). By con-
trast, no remarkable difference was found in the infectivity
between VSVs pseudotyped with BatIV glycoproteins (i.e., HA
alone vs. HA and NA). These data suggest that, unlike the other
IAVs, the target molecules of BatIV HAs and NAs are different and
that the “HA–NA balance” concept proposed for IAVs does not be
applied to BatIVs.
Because H17N10 and H18N11 BatIVs have never been isolated,
their ability to infect humans and other mammals and the
pathogenic potential for these hosts can only be hypothesized. In
this study, the replication-incompetent VSV pseudotype system
enabled us to investigate the cellular tropism controlled by the
interaction between BatIV HA and its cellular ligand, which might
be some glycoproteins. Although a reverse genetics approach and
in vivo experiments for the infectious BatIV are needed to provide
direct evidence of its pathogenicity and host speciﬁcity, our data
suggest that BatIV may preferentially infect particular bat species.Materials and methods
Cells
HEK293, HEK293T, and Vero E6 cells were grown in Dulbecco's
modiﬁed Eagle's medium (DMEM) with 10% fetal calf serum (FCS)
and penicillin–streptomycin. MDCK cells were grown in Dulbec-
co's modiﬁed Eagle's medium (DMEM) with 10% calf serum, L-
glutamine, and penicillin–streptomycin. Bat cell lines BKT1, FBKT1,
YubFKT1, IndFSPT1, DemKT1, ZFBK11-97, SuBK12-08, and ZFBS13-
76A were established as described previously (Maeda et al., 2008;
Maruyama et al., 2014). All bat cell lines were grown in RPMI-1640
medium with 10% FCS, L-glutamine, and penicillin–streptomycin.
Construction of plasmids expressing HAs and NAs
Coding regions of the HAs and NAs of BatIVs were synthesized
in vector pUC19 or pUCFa, based on the nucleotide sequences of
GenBank (accession numbers for H17 HA, N10 NA, H18 HA, and
N11 NA: CY103892, CY103894, CY125945, and CY125947, respec-
tively) (FASMAC). Each coding region of the viral proteins was
ampliﬁed by PCR with primers including restriction sites, the
kozak sequence, and the stop codon. After digestion by restriction
enzymes, each gene was cloned into the mammalian expression
vector pCAGGS (Niwa et al., 1991). H1 HA and N1 NA of A/WSN/
1933 (H1N1) (WSN), and H3 HA and N2 NA of A/Aichi/2/1968
(H3N2) (Aichi) were cloned into pCAGGS as described previously
(Muramatsu et al., 2013).Vesicular stomatitis viruses (VSVs) pseudotyped with HAs and/or NAs
Using VSV containing the green ﬂuorescent protein (GFP) gene
instead of the receptor-binding VSV G protein gene (VSVΔG*-G),
pseudotyped viruses with HAs and/or NAs of BatIVs, WSN, and
Aichi were generated as described previously (Takada et al., 1997).
VSVs pseudotyped with IAV glycoproteins were pretreated with
trypsin (ﬁnal concentration 0.0005%) for 30 min at 37 °C, followed
by incubation with an anti-VSV G monoclonal antibody, VSV-G(N)
1-9, to abolish the background infectivity of parental VSVΔG*-G
(Nakayama et al., 2011). For virus titration, 10-fold diluted pseu-
dotyped VSVs were inoculated into conﬂuent monolayers of each
cell line on 96-well plates, and the infectious unit (IU) in each cell
line was determined 20 hours later by counting the number of
GFP-expressing cells under a ﬂuorescent microscope.
Electron microscopy
Transmission electron microscopy was carried out as described
previously (Maruyama et al., 2014). Pseudotyped VSVs ﬁxed with
0.25% glutaraldehyde were adsorbed to collodion-carbon-coated
copper grids and negatively stained with 2% phosphotungstic acid
solution (pH¼5.8). For immune transmission electron microscopy,
we used an anti-HA2 monoclonal antibody (3N12-6-4) broadly
cross-reactive to group 1 HA subtypes, anti-N10 NA mouse serum
(FM0137) produced by immunization with a synthetic peptide
corresponding to amino acid residues 328–343 (AQEKGEGGIQG-
FILDE) of N10 NA, and an immunogold-conjugated goat anti-
mouse IgG (HþL) polyclonal antibody (BB International). Sam-
ples were examined with an H-7650 electron microscope (Hitachi)
at 80 kV.
SDS-PAGE and western blotting
Pseudotyped VSVs were treated with or without trypsin (ﬁnal
concentration 0.0005%) for 30 min at 37 °C and then mixed with
SDS-PAGE sample buffer with 5% 2-mercaptoethanol and boiled
for 5 minutes. After electrophoresis on 5–20% SuperSep (Wako),
separated proteins were blotted on a polyvinylidene diﬂuoride
membrane (Millipore). The membrane was incubated with an
anti-H3N2 chicken polyclonal antiserum or anti-HA2 monoclonal
antibody 3N12-6-4, which reacts to H1, H2, H5, H6, H17, and H18
HAs, followed by incubation with peroxidase-conjugated rabbit
anti-chicken IgY (HþL) or goat anti-mouse IgG (HþL) (Jackson
ImmunoResearch). The bound antibodies were visualized with
Immobilon Western (Millipore).
Cell treatment with enzymes and inhibitors
IndFSPT1 cells were preincubated with the medium containing
an endosomal acidiﬁcation inhibitor, ammonium chloride (Wako),
at 37 °C for 2 h in a CO2 incubator, and then infected with pseu-
dotyped VSVs appropriately diluted to yield 200–1000 IUs, fol-
lowed by incubation in the presence of ammonium chloride.
IndFSPT1 cells were also pretreated with pronase (a mixture of
endo- and exoproteases from Streptomyces griseus) (Calbiochem)
(Narahashi et al., 1968), for 20 min, an N-glycosylation inhibitor
(tunicamycin from Streptomyces sp.) (Sigma) for 8 h, which blocks
the reaction of UDP-GlcNAc and dolichol phosphate in the ﬁrst
step of glycoprotein synthesis, thus inhibiting the synthesis of N-
linked glycoproteins, or neuraminidase from Vibrio cholerae
(Roche) (Uchida et al., 1977) for 1 h at 37 °C in a CO2 incubator.
Treated cells were washed with serum free RPMI-1640 medium
3 times, and then incubated with pseudotyped VSVs appropriately
diluted to yield 200–1000 IUs for 1 h. After adsorption of the virus,
the inoculum was aspirated and the growth medium (10% FCS
J. Maruyama et al. / Virology 488 (2016) 43–50 49RPMI-1640 medium) was added. Cells were incubated for 20 h,
and infected cells were counted under a ﬂuorescent microscope.
Cell viabilities were assessed by the alamar blue assay. After
treatments of each enzyme and inhibitor, cells were incubated
with FCS-free RPMI-1640 medium containing 10% Alamar blue
(Biosource) for 2 h, and ﬂuorescence with excitation wavelength at
530–560 nm was measured using EnVision (PerkinElmer).Acknowledgments
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